After more than two decades of helping freestanding, single-specialty endoscopic ASCs thrive across the U.S., Physicians Endoscopy is entering the next phase of growth and development. The company, which has partnerships with 60 gastroenterology surgery centers and more than 600…
GI & Endoscopy
Motus GI is on track to grow its Pure-Vu endoscopy system in 2021, according to CEO Tim Moran. He spoke on four value-creation drivers — reimbursement, product innovation, clinical data and strategic partnerships — in an earnings call transcribed by…
From studies on colorectal cancer risk factors to research on outpatient colonoscopies, here are nine recent studies catching the eyes of gastroenterologists:
Motus GI shared its fourth-quarter and full-year 2020 financial results, posting a $19.3 million net loss for the year, or a $0.60 loss per diluted share.
GI OnDemand, a joint venture between the American College of Gastroenterology and Gastro Girl, partnered with Ambry Genetics on genetic counseling and testing.
Advertisement
Douglas Adler, MD, is joining Colorado Springs-based Peak Gastroenterology Associates and will start in April.
CRH Medical reported an uptick in fourth-quarter revenue in 2020 compared to 2019, but saw a year-over-year drop in the first through third quarters of 2020.
The FDA granted Check-Cap's C-Scan an investigational device exemption March 15 that will allow the test to launch a clinical study in the U.S.
A blood-based colorectal cancer test was found to be the most cost-effective alternative colorectal cancer test for people who didn't want a colonoscopy or fecal immunochemical test, according to a study published in the Journal of the National Cancer Institute.
Dallas-based GI Alliance is the biggest private equity-backed gastroenterology platform in the U.S.